Elevance Health (ELV) Other financing activities (2010 - 2026)

Elevance Health (ELV) has 15 years of Other financing activities data on file, last reported at -$3.0 million in Q1 2026.

• Other financing activities for Q1 2026 came in at -$3.0 million, up 78.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.0 million (up 306.25% YoY), and the FY2025 annual result was $22.0 million, up 1000.0% from the prior year.
• Other financing activities slipped to -$3.0 million in Q1 2026 per ELV's latest filing, from $12.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $25.0 million in Q4 2022 and troughed at -$14.0 million in Q1 2025.
• A 5-year average of $4.3 million and a median of $3.5 million in 2023 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2024 and 2025: Other financing activities plunged 450.0% in 2024, then jumped 2000.0% in 2025.
• A 5-year view of Other financing activities shows it stood at $25.0 million in 2022, then tumbled by 92.0% to $2.0 million in 2023, then sank by 450.0% to -$7.0 million in 2024, then jumped by 271.43% to $12.0 million in 2025, then slumped by 125.0% to -$3.0 million in 2026.
• Business Quant data shows ELV's Other financing activities at -$3.0 million in Q1 2026, $12.0 million in Q4 2025, and $21.0 million in Q3 2025.